Fig. 4From: EZH2 in hepatocellular carcinoma: progression, immunity, and potential targeting therapiesClassification and mechanism of EZH2 inhibitors. Three different types of EZH2 inhibitory mechanisms are demonstrated: inhibition of the methyltransferase activity of EZH2, promotion of EZH2 degradation, and disruption of the interaction among EZH2 and other PRC2 componentsBack to article page